Bioventure FZ-LLC (“BV”) is a UAE-based biopharmaceutical company with a global network, focused on biotech and a wide range of pharmaceutical activities, delivering world-class solutions within the UAE and the Middle East.
BV specializes in biotech and generics commercialization, tech transfer and in/out-licensing activities. BV currently holds 2.5% stake in Alvotech and signed an agreement for an exclusive distribution and commercialization of Alvotech’s biosimilar portfolio across the Middle East and Africa. In addition, BV enjoys exclusive partnership and distribution rights regarding the sale of Alvogen’s targeted generic pharmaceuticals portfolio across the Middle East and North Africa region. The portfolio consists of 28 generic pharmaceuticals in the field of oncology, autoimmune and inflammation and blood disease.
Dubai Science Park, 1102N, HQ Complex, Dubai, UAE